TSHA Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4

12 days ago - By: Benzinga - Mentions: EXEL CCM CLLS GMAB ...

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

15 days ago - By: Benzinga

Why Is Taysha Gene Therapies Stock Falling Friday?

16 days ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome

23 days ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting

a month ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Stocktwits

Taysha Gene Therapies Stock Soars To 3-Year High After FDA Boost — Wall Street Calls Rett Drug ‘Derisked’ And Ahead Of Rivals

a month ago - By: Stocktwits - Mentions: IWMW TXSS TSLA

Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy

a month ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome

2 months ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Zacks Investment Research - Mentions: PINC

Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Beats Revenue Estimates

3 months ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Zacks Investment Research - Mentions: AMPH

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates

3 months ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12

3 months ago - By: Zacks Investment Research - Mentions: AMPH

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know

3 months ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Yahoo Finance

BofA Securities Affirms ‘Buy’ Rating on Taysha Gene Therapies (TSHA) on TSHA-102 Prospects

4 months ago - By: Zacks Investment Research

Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade

4 months ago - By: Yahoo Finance - Mentions: VZ SRPT

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory

4 months ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Yahoo Finance - Mentions: GS

Cantor Fitzgerald Reiterates “Overweight” Rating on Taysha (TSHA) for Positive TSHA-102 Clinical Data

4 months ago - By: Yahoo Finance - Mentions: REGN

Jefferies Maintains a Buy on Taysha Gene Therapies (TSHA) With an $8 PT

5 months ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Stocktwits

Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data

5 months ago - By: Taysha Gene Therapies, Inc.

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

TAYSHA GENE THERAPIES INC (TSHA) Stock News

TSHA Latest News, Press Relases and Analysis